Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Mark Brooks
AddedMar 31, 2024
UpdatedMay 31, 2026
Mark Brooks

Mark Brooks

Co-Founder, Granite Growth Health Partners

CrunchbaseLinkedIn

Mark Brooks's Career

Granite Growth Health Partners
Granite Growth Health Partners

Hillsborough Township, NJ, US

Co-Founder
Oraya Therapeutics
Oraya Therapeutics

Newark, CA, US

Board Member· Board
QualDerm Partners
QualDerm Partners

Brentwood, TN, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Mark Brooks's Career

Granite Growth Health Partners
Granite Growth Health Partners
Investment FirmInvestment Firm62017Hillsborough Township, NJ, US
Co-Founder

Leadership at Granite Growth Health Partners

Diane M. DaychDiane M. DaychCo-Founder

Similar to Granite Growth Health Partners

Granite Capital ManagementGranite Capital ManagementNew York City, NY, USest. 2000Granite Capital ManagementNew York City, NY, US · est. 2000

Granite Capital Management LLC: A New York-based private equity firm specializing in financial services.

Investment Firm8
Black Granite CapitalBlack Granite CapitalWhite Plains, NY, USest. 2014Black Granite CapitalWhite Plains, NY, US · est. 2014

Black Granite Capital LLC: A NY-based private equity firm investing in healthcare and tech sectors.

Investment Firm6
Granite PartnersGranite PartnersToronto, Ontario, CAest. 1996Granite PartnersToronto, Ontario, CA · est. 1996

Granite Partners: A Canadian private equity firm, targeting profitable manufacturing and service companies for value growth.

Investment Firm750
Healthcare Equity PartnersHealthcare Equity PartnersChicago, IL, USest. 1996Healthcare Equity PartnersChicago, IL, US · est. 1996

Chicago-based financial services firm investing in healthcare growth companies.

Investment Firm5
Oraya Therapeutics
Oraya Therapeutics
Angel$97.3M752006Newark, CA, US
Board Member· Board

Leadership at Oraya Therapeutics

Reza ZadnoReza ZadnoBoard Member
Brian HalakBrian HalakBoard Member
John OnopchenkoJohn OnopchenkoBoard Member
Michael GertnerMichael GertnerBoard Member
Jim TaylorJim TaylorBoard Member
Christian MüllerChristian MüllerBoard Member
QualDerm Partners
QualDerm Partners
Private Equity$31.8M1k2014Brentwood, TN, US
Board Member· Board

Leadership at QualDerm Partners

Gene FlemingGene FlemingBoard Member
Bill SouthwickBill SouthwickCEO
Barry LeshinBarry LeshinFounder

Similar to QualDerm Partners

NavaDermNavaDermMillburn, NJ, USDermatologyest. 2018NavaDermMillburn, NJ, US · est. 2018

NavaDerm: A dermatology management platform supporting 40+ dermatologists across NY and NJ.

Series C · $30M75
Direct DermatologyDirect DermatologyPalo Alto, CA, USDermatology, Telehealthest. 2010Direct DermatologyPalo Alto, CA, US · est. 2010

DirectDerm: Immediate access to top US dermatologists for skin-related medical consultations.

Series B · $240k35
VitalSkin DermatologyVitalSkin DermatologyDecatur, IL, USCosmetic Dermatology, Medical Dermatology, Skin Cancer Treatmentest. 2019VitalSkin DermatologyDecatur, IL, US · est. 2019

VitalSkin Dermatology: A patient-focused practice enhancing skin health and wellness since 2019.

Seed · $1.1M69
Skin PharmSkin PharmNashville, TN, USSkincareest. 2017Skin PharmNashville, TN, US · est. 2017

Skin Pharm: A cosmetic dermatology practice offering expert skincare treatments.

Private Equity · $15M35

Mark Brooks's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Mark Brooks

Mark GoodmanMark GoodmanFounder · Terawatt VenturesScott NolanScott NolanPartner · Founders FundAlexander NiehenkeAlexander NiehenkeBoard Member · Bill.com HoldingsAndy VitusAndy VitusBoard Member · JFrogFrank MendicinoFrank MendicinoCo-Founder · Access Venture PartnersMichael BankMichael BankCo-Founder · Blip